Evoke Pharma Inc. buy krebskrebs
Start price
28.06.21
/
50%
€14.52
Target price
28.06.22
€30.00
Performance (%)
-80.69%
End price
29.06.22
€2.80
Summary
This prediction ended on 29.06.22 with a price of €2.80. The BUY prediction by krebskrebs for Evoke Pharma Inc. performed very badly with a performance of -80.69%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evoke Pharma Inc. | - | - | - | - |
iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
Comments by krebskrebs for this prediction
In the thread Evoke Pharma Inc. diskutieren
Buy mit Kursziel 2,5
In the thread Trading Evoke Pharma Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten